Valuation: Nanologica AB

Market Cap 54.25M 5.52M 4.95M 4.55M 4.12M 7.7M 524M 7.85M 21.78M 276M 20.72M 20.28M 870M P/E 2026 *
-
P/E 2027 * -
Enterprise Value 54.25M 5.52M 4.95M 4.55M 4.12M 7.7M 524M 7.85M 21.78M 276M 20.72M 20.28M 870M EV / Sales 2026 *
0.49x
EV / Sales 2027 * 0.3x
Free-Float
32.62%
Yield 2026 *
-
Yield 2027 * -
1 day-2.94%
1 week-8.08%
Current month-46.08%
1 month-46.08%
3 months-63.89%
6 months-69.10%
Current year-78.85%
1 week 0.16
Extreme 0.1605
0.18
1 month 0.16
Extreme 0.16
0.31
Current year 0.16
Extreme 0.16
2.25
1 year 0.16
Extreme 0.16
2.25
3 years 0.16
Extreme 0.16
11.9
5 years 0.16
Extreme 0.16
17.45
10 years 0.16
Extreme 0.16
20
Manager TitleAgeSince
Chief Executive Officer 60 2026-10-22
Investor Relations Contact - -
Corporate Officer/Principal 57 2023-12-31
Director TitleAgeSince
Chairman 68 2013-12-31
Director/Board Member 63 2013-12-31
Director/Board Member 57 2018-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
12/21/21 Buy 115,000 0.4083%
6/9/21 Buy

Director

13,000 0.0468%
6/8/21 Buy

Chief Executive Officer

82,566 0.2971%
Change 5-day change 1-year change 3-year change Capi.($)
-2.94%-8.08%-86.96%-98.42% 5.67M
+0.70%+5.01%+17.85%+90.37% 84.34B
+1.46%-0.50%+19.49%+32.97% 43.75B
+0.42%-0.61%+14.00%-16.35% 34.63B
+1.86%+1.83%+13.13%+18.20% 33.66B
-0.71%-4.05%+18.13%+47.75% 32.38B
+0.75%+3.33%-1.71%+29.41% 26.34B
-0.12%-3.77%+52.03%+38.08% 23.89B
-0.38%+2.56%-42.70%-35.95% 18.98B
-3.05%-4.36%+13.31%+12.15% 16.1B
Average -0.20%-3.69%+1.66%+11.82% 31.41B
Weighted average by Cap. +0.44%+0.45%+14.24%+37.74%

Financials

2026 *2027 *
Net sales 112M 11.35M 10.16M 9.35M 8.47M 15.84M 1.08B 16.13M 44.76M 567M 42.59M 41.69M 1.79B 179M 18.22M 16.32M 15.01M 13.6M 25.42M 1.73B 25.9M 71.86M 910M 68.38M 66.93M 2.87B
Net income - -
Net Debt - -
Projected Income Statement - Annual - Nanologica AB
Logo Nanologica AB
Nanologica AB (publ) is a Sweden-based materials development company. The Company specializes in developing nanoporous materials from nanoporous silica (silicon dioxide) for a variety of applications, ranging from purification to pharmaceutical excipients. The Company's core competency has been developed and expanded in two areas of application, in particular: Drug Delivery and Chromatography, a technology used for the separation and purification of products on the market and in development. The Company's Drug Delivery sector operates within a niche domain of nanocarriers. Nanologica AB (publ)’s drug delivery technology is aimed on absorption of the medicine by the body for drugs that are poorly soluble in water.
Employees
72
Date Price Change Volume
26-10-30 SEK 0.1650 -2.94% 341,324
26-10-29 SEK 0.1700 +1.49% 669,091
26-10-28 SEK 0.1675 +3.40% 269,467
26-10-27 SEK 0.1620 -4.99% 756,322
26-10-26 SEK 0.1705 -5.01% 653,464

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Nanologica AB
  1. Stock Market
  2. Stocks
  3. NICA Stock